Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

We investigated the safety and efficacy of a methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) combination regimen as second-line chemotherapy for patients with advanced or metastatic transitional cell carcinoma who failed first-line gemcitabine and cisplatin (GC) chemotherapy. Thirty pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Han, K S, Joung, J Y, Kim, T S, Jeong, I G, Seo, H K, Chung, J, Lee, K H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2008
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359702/
https://ncbi.nlm.nih.gov/pubmed/18087289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados